Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FSCN1 as a new druggable target in adrenocortical carcinoma.
Ruggiero C, Tamburello M, Rossini E, Zini S, Durand N, Cantini G, Cioppi F, Hantel C, Kiseljak-Vassiliades K, Wierman ME, Landwehr LS, Weigand I, Kurlbaum M, Zizioli D, Turtoi A, Yang S, Berruti A, Luconi M, Sigala S, Lalli E. Ruggiero C, et al. Among authors: wierman me. Int J Cancer. 2023 Jul 1;153(1):210-223. doi: 10.1002/ijc.34526. Epub 2023 Mar 31. Int J Cancer. 2023. PMID: 36971100
Response of adrenocortical carcinoma liver metastases to hepatic artery infusion floxuridine.
McDonald HG, Sarvestani AL, Owen JW, Rueckert J, Wierman ME, Kiseljak-Vassiliades K, Pandalai PK, Ellis CS, Patel RA, Del Rivero J, Hernandez JM, Cavnar MJ. McDonald HG, et al. Among authors: wierman me. HPB (Oxford). 2023 Nov;25(11):1446-1449. doi: 10.1016/j.hpb.2023.06.014. Epub 2023 Jun 24. HPB (Oxford). 2023. PMID: 37453816 No abstract available.
PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma.
Warmington E, Smith G, Chortis V, Liang R, Lippert J, Steinhauer S, Landwehr LS, Hantel C, Kiseljak-Vassiliades K, Wierman ME, Altieri B, Foster PA, Ronchi CL. Warmington E, et al. Among authors: wierman me. Endocr Connect. 2023 Dec 14;13(1):e230403. doi: 10.1530/EC-23-0403. Print 2024 Jan 1. Endocr Connect. 2023. PMID: 37992487 Free PMC article.
Effects of follicle-stimulating hormone on energy balance and tissue metabolic health after loss of ovarian function.
Libby AE, Solt CM, Jackman MR, Sherk VD, Foright RM, Johnson GC, Nguyen TT, Breit MJ, Hulett N, Rudolph MC, Roberson PA, Wellberg EA, Jambal P, Scalzo RL, Higgins J, Kumar TR, Wierman ME, Pan Z, Shankar K, Klemm DJ, Moreau KL, Kohrt WM, MacLean PS. Libby AE, et al. Among authors: wierman me. Am J Physiol Endocrinol Metab. 2024 May 1;326(5):E626-E639. doi: 10.1152/ajpendo.00400.2023. Epub 2024 Mar 27. Am J Physiol Endocrinol Metab. 2024. PMID: 38536037
Should Dehydroepiandrosterone Be Administered to Women?
Wierman ME, Kiseljak-Vassiliades K. Wierman ME, et al. J Clin Endocrinol Metab. 2022 May 17;107(6):1679-1685. doi: 10.1210/clinem/dgac130. J Clin Endocrinol Metab. 2022. PMID: 35254428 Free PMC article. Review.
Targeted genomic analysis of 364 adrenocortical carcinomas.
Pozdeyev N, Fishbein L, Gay LM, Sokol ES, Hartmaier R, Ross JS, Darabi S, Demeure MJ, Kar A, Foust LJ, Koc K, Bowles DW, Leong S, Wierman ME, Kiseljak-Vassiliades K. Pozdeyev N, et al. Among authors: wierman me. Endocr Relat Cancer. 2021 Aug 16;28(10):671-681. doi: 10.1530/ERC-21-0040. Endocr Relat Cancer. 2021. PMID: 34410225 Free PMC article.
143 results